Caseware UK (AP4) 2023.0.135 2023.0.135 2024-02-292024-02-292023-03-01falseNo description of principal activity22falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 06827849 2023-03-01 2024-02-29 06827849 2022-03-01 2023-02-28 06827849 2024-02-29 06827849 2023-02-28 06827849 c:Director1 2023-03-01 2024-02-29 06827849 d:Buildings 2023-03-01 2024-02-29 06827849 d:Buildings 2024-02-29 06827849 d:Buildings 2023-02-28 06827849 d:Buildings d:OwnedOrFreeholdAssets 2023-03-01 2024-02-29 06827849 d:FurnitureFittings 2023-03-01 2024-02-29 06827849 d:FurnitureFittings 2024-02-29 06827849 d:FurnitureFittings 2023-02-28 06827849 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-03-01 2024-02-29 06827849 d:OwnedOrFreeholdAssets 2023-03-01 2024-02-29 06827849 d:CurrentFinancialInstruments 2024-02-29 06827849 d:CurrentFinancialInstruments 2023-02-28 06827849 d:CurrentFinancialInstruments d:WithinOneYear 2024-02-29 06827849 d:CurrentFinancialInstruments d:WithinOneYear 2023-02-28 06827849 d:ShareCapital 2024-02-29 06827849 d:ShareCapital 2023-02-28 06827849 d:RetainedEarningsAccumulatedLosses 2024-02-29 06827849 d:RetainedEarningsAccumulatedLosses 2023-02-28 06827849 c:OrdinaryShareClass1 2023-03-01 2024-02-29 06827849 c:OrdinaryShareClass1 2024-02-29 06827849 c:OrdinaryShareClass1 2023-02-28 06827849 c:FRS102 2023-03-01 2024-02-29 06827849 c:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 06827849 c:FullAccounts 2023-03-01 2024-02-29 06827849 c:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 06827849 2 2023-03-01 2024-02-29 06827849 e:PoundSterling 2023-03-01 2024-02-29 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 06827849










INIYA MEDICAL SERVICES LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 29 FEBRUARY 2024

 
INIYA MEDICAL SERVICES LIMITED
REGISTERED NUMBER: 06827849

BALANCE SHEET
AS AT 29 FEBRUARY 2024

29 February
28 February
2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
158,032
158,081

  
158,032
158,081

Current assets
  

Cash at bank and in hand
 5 
812,268
683,053

  
812,268
683,053

Current liabilities
  

Creditors: amounts falling due within one year
 6 
(63,072)
(30,136)

Net current assets
  
 
 
749,196
 
 
652,917

Total assets less current liabilities
  
907,228
810,998

  

Net assets
  
907,228
810,998


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
907,128
810,898

  
907,228
810,998


Page 1

 
INIYA MEDICAL SERVICES LIMITED
REGISTERED NUMBER: 06827849

BALANCE SHEET (CONTINUED)
AS AT 29 FEBRUARY 2024

The Director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Dr. R. Natesan
Director
Date: 6 August 2024

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
INIYA MEDICAL SERVICES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

1.


General information

Iniya Medical Services Limited is a private company limited by shares and incorporated in England and Wales its registered number is: 06827849. The Company's registered office is: C/O James Cowper Kreston, 8th Floor South, Reading Bridge House, George Street, Reading, Berkshire, RG1 8LS.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessor

Rental income from operating leases is credited to profit or loss on a straight-line basis over the lease term.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
INIYA MEDICAL SERVICES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the policies laid out below.

Depreciation is provided on the following basis:

Freehold property
-
none
Fixtures and fittings
-
15% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
INIYA MEDICAL SERVICES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Tangible fixed assets







Freehold property
Fixtures and fittings
Total

£
£
£



Cost or valuation


At 1 March 2023
157,753
8,572
166,325



At 29 February 2024

157,753
8,572
166,325



Depreciation


At 1 March 2023
-
8,244
8,244


Charge for the year on owned assets
-
49
49



At 29 February 2024

-
8,293
8,293



Net book value



At 29 February 2024
157,753
279
158,032



At 28 February 2023
157,753
328
158,081

Page 5

 
INIYA MEDICAL SERVICES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

5.


Cash and cash equivalents

29 February
28 February
2024
2023
£
£

Cash at bank and in hand
812,268
683,053



6.


Creditors: Amounts falling due within one year

29 February
28 February
2024
2023
£
£

Corporation tax
28,865
22,042

Other creditors
31,607
5,619

Accruals and deferred income
2,600
2,475

63,072
30,136



7.


Share capital

29 February
28 February
2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



Page 6